|
|
EQUINE SAFETY
ZONE’s predecessor,
ARDA (Army Research and Development Activity), later ARDA-MEDCO, was started 18
years ago to RESEARCH combat-related medical problems and DEVELOP solutions
that would be effective even under the most unimaginable conditions.
In 1991,
ARDA-19 was tested and approved by the Surgeon General for use by all branches
of the Armed Services and all federal agencies and was issued a Federal
Contract by the Department of Defense.
Subsequently,
49 variations of ARDA-19 were formulated and tested resulting in a master,
patented formulation of six d distinct antimicrobial agents that can be
manipulated to attack and destroy the specific organisms responsible for
disease conditions in horses. Ninety-nine percent of these organisms are killed
on contact with any of our products – EVEN when we dilute our product down to
1:32,000. Independent Laboratory testing was used and is availabl, to
substantiate this claim. Our chief formulation chemist has been issued 63
US patents in antimicrobial chemistry (available
upon request) and has coordinated the prosecution and maintenance of a roster
of 300
US patents and trademarks.
Equine Dermatological Problems
“Skin disease in horses can be singularly
distressing to many owners and so it is not surprising that if we, as animal
health professionals, fail to solve problems, owners resort to often unproved
and even harmful remedies to treat their horses. This frequently leads to
a clinical deterioration and often an alteration in the clinical appearance of
the condition. It can become increasingly difficult to reach either a
definitive diagnosis or a successful outcome.” '
1. Pascoe RRR and
Knottenbelt
D.C. (1999) Preface. IN: Manual of Equine Dermatology. WB Saunders
Philadelphia, pp. Preface.
• Any antimicrobial will have some
limited effect on a bacterial or fungal cause of dermatological pathology.
• Many commercially available
over-the-counter antimicrobial preparations have mild to extremely harmful and
painful side effects.
• One company stands alone in their
approach to solving dermatological problems in horses—our philosophy becomes
our science and our science ultimately becomes our product.
Our Philosophy
• Identify
a skin disease syndrome and the causative organism(s)
• Review
the literature, historical treatments, and current products available
used to treat a specific problem
• Evaluate
what is being done to treat a disease and the mechanisms involved in trying to
effect a “cure”
• Analyze
the side effects of any given treatment
Only
then, if we can RESOLVE the
condition better, faster, safer, do we set about to create a product without
side affects or clinical deterioration or alterations of the clinical
appearance of the condition. ResolveA19 for
rainrot, ringworm, and thrush in their final form exceeded even our expectations.
|
|
|